SAN FRANCISCO — In closing arguments for Medivation Inc., lawyers at Latham & Watkins accused a UCLA researcher of cheating the pharmaceutical company out of a $1 billion prostate cancer treatment and asked a jury to award $15 million.

But on Friday, the jury in San Francisco Superior Court gave them far less: $406,917.